HSBC Holdings’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

HSBC Holdings’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,529,416	Closed	-$18.9M	–	3340
2024 Q4	$18.9M	Buy	+1,529,416	New	+$17.5M	0.01%	747
2023 Q1	–	Sell	-13,444	Closed	-$180K	–	3123
2022 Q4	$180K	Buy	13,444 +1,731	+15%	+$26.5K	﹤0.01%	2797
2022 Q3	$227K	Sell	11,713 -4,622	-28%	-$84.2K	﹤0.01%	2571
2022 Q2	$249K	Sell	16,335 -1,689	-9%	-$25K	﹤0.01%	2750
2022 Q1	$376K	Buy	18,024 +6,931	+62%	+$141K	﹤0.01%	2615
2021 Q4	$327K	Buy	+11,093	New	+$317K	﹤0.01%	2733

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HSBC Holdings's CDMO Position: Q1 2025 in Review

HSBC Holdings sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 1,529,416 shares — an estimated $18.9M sold.

HSBC Holdings first reported a position in CDMO in Q4 2021 and held it in 6 quarters. The position peaked at $18.9M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

HSBC Holdings reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
HSBC Holdings sold 1,529,416 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $18.9M.
HSBC Holdings first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
HSBC Holdings's Avid Bioservices, Inc. Common Stock position peaked at $18.9M in Q4 2024.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on HSBC Holdings's 13F filing for Q1 2025, filed 14 May 2025.